BB1 · ASX

Blinklab Limited (ASX:BB1)

AU$0.36

 0.01 (2.857%)
ASX:Live
24/04/2025 10:26:06 AM
HALO Ords HALO Consensus Value GROWTH AUS All-Consensus All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

BB1 Overview

BB1 Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

BB1 Price Chart

Key Stats

Market Cap

AU$23.80M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.2 - 0.48

Trade Value (12mth)

AU$18,409.00

1 week

0%

1 month

-13.25%

YTD

26.32%

1 year

28.57%

All time high

0.48

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Technology

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

BB1 Announcements

Latest Announcements

Date Announcements

01 April 25

BlinkLab Surpasses Key Milestone in Pivotal U.S. Trial

×

BlinkLab Surpasses Key Milestone in Pivotal U.S. Trial

31 March 25

Trading Halt

×

Trading Halt

31 March 25

Pause in Trading

×

Pause in Trading

20 March 25

Brokers meet Biotech Presentation

×

Brokers meet Biotech Presentation

19 March 25

Blinklab Expands Autism Diagnostics into Adults

×

Blinklab Expands Autism Diagnostics into Adults

12 March 25

US Autism Diagnostic Study Commences with First Child Tested

×

US Autism Diagnostic Study Commences with First Child Tested

27 February 25

Section 708(A) Notice

×

Section 708(A) Notice

27 February 25

Application for quotation of securities - BB1

×

Application for quotation of securities - BB1

26 February 25

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

10 February 25

North Shore Pediatric Therapy in Chicago joins Study

×

North Shore Pediatric Therapy in Chicago joins Study

05 February 25

BlinkLab Initiates its First US-based Clinical Site

×

BlinkLab Initiates its First US-based Clinical Site

30 January 25

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

14 January 25

Change of Director's Interest Notice

×

Change of Director's Interest Notice

14 January 25

Change of Director's Interest Notice

×

Change of Director's Interest Notice

10 January 25

Change of Director's Interest Notice

×

Change of Director's Interest Notice

10 January 25

Change of Director's Interest Notice

×

Change of Director's Interest Notice

10 January 25

Change of Director's Interest Notice

×

Change of Director's Interest Notice

07 January 25

Change of Director's Interest Notice

×

Change of Director's Interest Notice

31 December 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

19 December 24

Positive Outcome from FDA Pre-Submission Meeting

×

Positive Outcome from FDA Pre-Submission Meeting

18 December 24

Trading Halt

×

Trading Halt

18 December 24

Pause in Trading

×

Pause in Trading

16 December 24

Application for quotation of securities - BB1

×

Application for quotation of securities - BB1

09 December 24

Notice of Release of Escrowed Securities

×

Notice of Release of Escrowed Securities

21 November 24

Amended BB1 to Participate in Monash Uni Autism/ADHD MAGNET

×

Amended BB1 to Participate in Monash Uni Autism/ADHD MAGNET

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

BB1 Shortsell

Frequently Asked Questions

The current share price of Blinklab Limited (BB1:ASX) is AU$0.36.
The 52-week high share price for Blinklab Limited (BB1:ASX) is AU$0.48.
The 52-week low share price for Blinklab Limited (BB1:ASX)? is AU$0.20.
Blinklab Limited (BB1:ASX) does not pay a dividend.
Blinklab Limited (BB1:ASX) does not pay a dividend.
Blinklab Limited (BB1:ASX) has a franking level of 0.0%.
Blinklab Limited (BB1:ASX) is classified in the Technology.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.